Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

LIPOSOME TECHNOLOGY FILES FOR OFFERING

Nov. 1, 1991

ANTICIPATED DATA PROPELS SYNERGEN STOCK

Oct. 31, 1991

CREATIVE BIO RAISES $14 MILLION IN STOCK SALE

Oct. 31, 1991

COR RAISES $36.5 MILLION IN OFFERING

Oct. 31, 1991

PRODUCT SALES DRIVE CHIRON EARNINGS

Oct. 31, 1991

AMBISOME APPROVED FOR SALE IN MEXICO, ITALY

Oct. 31, 1991

ENVIROGEN COMPLETES FINANCING ROUND

Oct. 31, 1991

CHIRON-CETUS VOTE DEC. 10

Oct. 30, 1991

FDA APPROVES BLOOD SUBSTITUTE TESTS

Oct. 30, 1991

ALLIANCE IMAGING AGENT ENTERS PHASE I

Oct. 30, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...